dyslipidemia

Documents about dyslipidemia

• Effectiveness of Motivational Interview in Patients With Dyslipidemia#904328ClinicalTrials.gov
• Fenofibrate in Dyslipidemia and Metformin-Controlled Diabetes#426757ClinicalTrials.gov
• Study of ARO-ANG3 in Adults With Mixed Dyslipidemia#810737ClinicalTrials.gov
• Bezafibrate Plus Berberine in Mixed Dyslipidemia#869447ClinicalTrials.gov
• Lipid Biomarker Study in Men With Dyslipidemia After Simvastatin Treatment (Study MK-0000-140)(COMPLETED)#888497ClinicalTrials.gov
• Management of Dyslipidemia in Adult Type 2 Diabetes Patients in India#897374ClinicalTrials.gov
• Phase 2 Dose-Finding Study Evaluating the Efficacy and Safety of EDP167 in Adults With Mixed Dyslipidemia#902702ClinicalTrials.gov
• Efficacy, Safety of Coadministered Pitavastatin and Valsartan in Patients With Hypertension and Dyslipidemia#405223ClinicalTrials.gov
• Longitudinal Study of Multi-Analyte Profile for Dyslipidemia#867628ClinicalTrials.gov
• Clinical Study for Patients With Hypertension Associated With Dyslipidemia#992726ClinicalTrials.gov
• Clinical Trial of YH14755 in Subjects With Dyslipidemia and Type II Diabetes#230381ClinicalTrials.gov
• A Study to Evaluate MK1903 in Patients With Dyslipidemia (MK1903-004)#854514ClinicalTrials.gov
• Dyslipidemia in Type 2 Diabetes (0767-034)#968139ClinicalTrials.gov
• Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination With Three Different Statins in Subjects With Mixed Dyslipidemia.#853505ClinicalTrials.gov
• A Study to Design a Model Cohort for Analysis of Dyslipidemia (MK-0653A-204)#245389ClinicalTrials.gov
• Trial to Evaluate the Efficacy of Fluvastatin on Certain Markers#832055ClinicalTrials.gov
• Fixed-dose Combination of Valsartan + Rosuvastatin Versus Their Isolated Components for Hypertension and Dyslipidemia.#882085ClinicalTrials.gov
• Crestor RUSH (The Efficacy of RosUvaStatin for Korean Dyslipidemia Patients With Hypertension )#894876ClinicalTrials.gov
• Characterization of Multi-dose RVX000222 in Combination With Statin Treatment in Dyslipidemia#892654ClinicalTrials.gov
• The Effects of Dietary Supplement of Coenzyme Q10（CoQ10） on Dyslipidemia#969744ClinicalTrials.gov
• Metformin/Rosuvastatin Combination Therapy With in Patients With Type 2 Diabetes and Dyslipidemia#279458ClinicalTrials.gov
• Study to Evaluate the EFFECTS of Acetylsalicylic Acid (ASA) on Niaspan®-Induced Flushing in Subjects With Dyslipidemia#873643ClinicalTrials.gov
• Metformin/Atorvastatin Combination Therapy in Subjects With Type II Diabetes and Dyslipidemia (Phase 3)#290959ClinicalTrials.gov
• Research on Burden of Disease for Patients With Myocardial Infarction Combining Dyslipidemia in China#807874ClinicalTrials.gov
• A Clinical Trial to Evaluate the Safety and Efficacy of ZYH7 Compared to Fenofibrate in Patients With Dyslipidemia#448238ClinicalTrials.gov
• Yangxin Dawayimixike Honey Paste for Carotid Atherosclerotic Plaque With Dyslipidemia: A Randomized Controlled Clinical Study#803831ClinicalTrials.gov
• Follow-on Protocol of Pitavastatin Versus Simvastatin in Patients With Hypercholesterolemia or Dyslipidemia and Coronary Heart Disease Risk Factors#866533ClinicalTrials.gov
• Efficacy, Safety, Tolerability And Actual Use Study Of Bococizumab And An Autoinjector (Pre-Filled Pen) In Subjects With Hyperlipidemia Or Dyslipidemia#873905ClinicalTrials.gov
• Efficacy and Safety of JS002 as Monotherapy in Patients With Primary Hypercholesterolaemia and Mixed Dyslipidemia#875092ClinicalTrials.gov
• Study to Compare the Efficacy and Safety of Pitavastatin and Simvastatin#884642ClinicalTrials.gov
• A Study of LY3561774 in Participants With Mixed Dyslipidemia#992475ClinicalTrials.gov
• A Study to Evaluate the Effects of Azilsartan on Coronary Artery Plaque in Essential Hypertensive Patients With Stable Angina and Dyslipidemia.#160238ClinicalTrials.gov
• 12-Month, Open-Label, Extension Study of LCP-AtorFen in Dyslipidemia#827453ClinicalTrials.gov
• Comparison of Intensive Versus Standard Care & Education for Dyslipidemia in Hypertension and Diabetes Patients#874850ClinicalTrials.gov
• LLM-CoManage: Large Language Model-Enabled Co-Management of Hypertension, Diabetes, and Dyslipidemia#900181ClinicalTrials.gov
• Bergamot and Cardio-Metabolic Risk Factors#873595ClinicalTrials.gov
• Acceptability Study of a New Fixed Combination of Fenofibrate 80 mg BID and Metformin 1000 mg BID in Type 2 Diabetes and Dyslipidemia#234403ClinicalTrials.gov
• COPANA - A09 PCSK 9 Substudy: Impact of Protease Inhibitors on PCSK9 Levels in Naive HIV-Infected Patients#810560ClinicalTrials.gov
• Assessment of Compliance With European and French Guidelines for the Management of Dyslipidaemias#840165ClinicalTrials.gov
• Study to Assess the Real World Effectiveness of Inclisiran in Chinese Adult Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia#896227ClinicalTrials.gov
• Genetic dyslipidemias#155989HAL (France)
• Safety and Efficacy Study Comparing ABT-143 to Simvastatin in Subjects With Elevated Levels of Low Density Lipoprotein Cholesterol ("Bad Cholesterol") and Triglycerides#858525ClinicalTrials.gov
• Efficacy and Safety of Berberine in the Treatment of Diabetes With Dyslipidemia#868245ClinicalTrials.gov
• Effect of Omega-3 Fatty Acids on Oxidative Stress and Dyslipidemia in Pediatric Patients Undergoing Hemodialysis#849661ClinicalTrials.gov
• A Thorough Corrected QT Interval Trial#811090ClinicalTrials.gov
• Association of Body Fatness With Hypertension, Dyslipidemia, and Myocardial Infarction in a Multinational Pooled Cohort#328074Scholar Commons
• A Clinical Study to Evaluate the Safety and Effectiveness of Inclisiran Sodium in Indian Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia#967224ClinicalTrials.gov
• Phase 3 Clinical Study Evaluating Efficacy, Safety, and Tolerability of Obicetrapib Vs Bempedoic Acid to Treat Dyslipidemia in Adults With Primary Non-familial Hypercholesterolemia or Mixed Dyslipidemia at High to Very High Cardiovascular Risk, During a Treatment Period of Approximately 84 Days#887843ClinicalTrials.gov
• An Observational Study Investigating the Change in Blood Cholesterol With Mevalotin® Tablet Administration in Korean Menopausal Women Aged 50 Years or More Who Require Treatment of Dyslipidemia#803748ClinicalTrials.gov
• Statins at the Primary Care Level#234566ClinicalTrials.gov